BioSig Technologies, Inc. STEX Common Stock Shares Outstanding
Common Stock Shares Outstanding at other companies
Other financials
Where this comes from
Reported directly by BioSig Technologies, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue.
The official record: BioSig Technologies, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioSig Technologies, Inc.'s common stock shares outstanding.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioSig Technologies, Inc.'s common stock shares outstanding?
- BioSig Technologies, Inc. (STEX) reported common stock shares outstanding of $1.71B in Q1 2026.
- How has BioSig Technologies, Inc.'s common stock shares outstanding changed year-over-year?
- BioSig Technologies, Inc.'s common stock shares outstanding increased by 365.3% year-over-year, from $367.44M to $1.71B.
- What is the long-term trend for BioSig Technologies, Inc.'s common stock shares outstanding?
- Over 3 years (2022 to 2025), BioSig Technologies, Inc.'s common stock shares outstanding has grown at a 1210.0% compound annual growth rate (CAGR), from $3M to $6.74B.
- What does common stock shares outstanding mean?
- This represents the total number of common shares held by all shareholders, including institutional investors and insiders. It serves as the denominator for calculating earnings per share and is a key indicator of potential equity dilution. Changes in this figure reflect share repurchases, new issuances, or conversion of convertible securities.